震惊!千亿创新药龙头暴涨14%,带领板块再创新高!

谈思生物
Jun 07, 2025

2025.06.07本文字数:543,阅读时长大约1.4分钟导读:港股创新药板块大涨,信达生物飙升13.6%!其“first-in-class”双抗IBI363在ASCO年会展示出色临床数据,获中美双重认可,摩根大通上调目标价,创新药行情火热来袭。千亿创新药龙头信达生物,涨近14%,创新药又有什么利好?创新药再迎行情,信达生物大涨近14%港股创新药板块再次迎来上涨,截止发稿港股创新药指数大涨...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10